Parties to the arrangement: University of Arkansas for Medical Sciences and Baptist Health

Date of arrangement: 04/07/2023

In accordance with the public disclosure requirements for the ACO Participation Waivers set forth in that Notice of Final Waivers in Connection with the Shared Savings Program, dated October 29, 2015, the following describes an arrangement involving A2 ACO, LLC (the “ACO”) that may require a waiver of applicable law, rules and regulations. The ACO’s governing board (the “ACO Board”) has duly authorized the arrangement below and made a bona fide determination that the arrangement is reasonably related to the purposes of the Medicare Shared Savings Program and assists the ACO in promoting quality patient care, lowering the cost of care and promoting population health care management (the “Triple Aim”). The details and rationale of such decision were recorded in a written resolution of the ACO Board and also detailed in the minutes related to such meeting.

The ACO has adopted certain oncology initiatives to assist the ACO in meeting the purposes of the Medicare Shared Savings Program with respect to Medicare beneficiaries who have been attributed to the ACO (“ACO Beneficiaries”).  The ACO has determined that having its members and participants, Baptist Health Medical Center – Little Rock and the University of Arkansas for Medical Science (UAMS), enter into an arrangement effective April 7, 2023 under which they collaborate to provide the professional and technical component of oncology services to ACO Beneficiaries through operation of the following on the campus of Baptist Health Medical Center – Little Rock: an outpatient oncology clinic (the “Oncology Clinic”), an outpatient infusion therapy center (the “Infusion Center”) and a hospital-based pharmacy that services the Oncology Clinic and Infusion Center, as provider-based joint ventures in accordance with 42 C.F.R. 413.65 (the “Provider-Based Oncology Services Arrangement”), is reasonably related to the purposes of the Medicare Shared Savings Program.  Through the Provider-Based Oncology Services Arrangement, the ACO is able to offer the following services to assist the ACO in meeting the Triple Aim for ACO Beneficiaries and to meet the oncology initiatives adopted by the ACO.

Items, services, goods, or facility provided:

• Development of educational programs for ACO Beneficiaries

• Development and implementation of preventative oncology measures designed to lower the risk of ACO Beneficiaries in developing cancer and needing oncology care

• Provision of early identification of cancer in ACO Beneficiaries

• Management and coordination of care for the ACO Beneficiaries needing oncology treatment

• Provision of oncology care through implementation of evidence-based oncology treatment protocols and

• Encouragement of investment in infrastructure and redesigned care processes to improve the quality and efficiency of service delivery for the ACO Attributed Beneficiaries needing oncology treatment

The ACO will develop processes and measures (i) to ensure that the Provider-Based Oncology Services Arrangement delivers the above services, (ii) to evaluate the effectiveness of the services and (iii) to refine the services in a manner that ensures their continued effectiveness.